Although the precise mechanisms of these effects remain unclear, it is likely that the interaction of MSG with T1R1/T1R3 umami receptors in the tongue of patients with head and neck cancer activates intracellular signals that elicit the expression of T1R3, thereby compensating for the inhibitory effect of chemotherapy. This evidence concerns the gene TAS1R1 and head and neck cancer.